Clinical Trial Management System Director accepts dual role as new IT Director for CTSI
The Clinical and Translational Science Institute (CTSI) congratulates Josh Fehrmann for taking on an expanded leadership role as IT Director for CTSI, as well as continuing work as Clinical Trial Management System (CTMS) Director.
As IT Director for CTSI, some of Fehrmann’s key responsibilities include:
- Develop, maintain, and communicate a strategic IT plan that integrates with CTSI Leadership’s strategic goals, and is informed by collaboration across CTSI
- Establish, prioritize, and communicate a holistic view of the CTSI IT work
- Strengthen existing CTSI IT applications (e.g., Portal, REDCap, StudyFinder, OnCore) through the facilitation of cross-team training, communication, and sharing of best practices
“I am thrilled to start serving in the IT Director role within CTSI and welcome the opportunity to expand and maintain strong IT partnerships with CTSI experts to continue the tradition of delivering IT solutions and innovations,” said Fehrmann.
In his dual role as CTMS Director, Fehrmann will continue to be responsible for OnCore — a mission-critical IT solution for CTSI, the health sciences, and the greater clinical research community at the University — as well as continue to lead the various OnCore cross-functional engagements.
“As CTMS Director, Josh has done an outstanding job of implementing, supporting and maturing a mission-critical enterprise system with broad reach and impact on clinical research,” said Constantin Aliferis, MD, PhD, Chief Research Informatics Officer and Director, Institute for Health Informatics.
Fehrmann has served as CTMS Director in CTSI’s Biomedical Informatics Program since 2016. Prior to joining CTSI in 2012, he held a series of progressively more responsible positions in the Masonic Cancer Center between 2001 and 2011. He has a BS in Computer Science from the University of Minnesota and is expected to receive his MS in Management of Technology in May 2020, also from the University.